Drug research firm Piramal Life Sciences today reported a net loss of Rs 31.47 crore for the quarter ended September 30, 2009, while it had a net loss of Rs 26.31 crore in the corresponding period last fiscal.

Net sales stood at Rs 2.55 crore for the quarter ended September, while the company did not provide sales figure for the same quarter in the previous fiscal, Piramal Life Sciences said in a filing to the Bombay Stock Exchange.

However, Piramal Life Sciences has reported a net sales of Rs 2.29 crore for the previous year ended March 31, 2009.

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Markets glued to gains - Nikkei rallies 1.6% to end just below 9,400 - Aluminium up 0.33% on global cues - Palm oil rebounds on global cues, up 0.5% - Mentha oil up marginally on spot demand

Tags : Piramal Life Sciences | Q2FY10 | results |   Read Business news in  Advertisements -  Now property search gets more exciting than ever before! -  High Growth Business Opportunities in Africa - Register to explore -  Medium-sized businesses are the engines of a smarter planet. -  Save over Rs.3000 with IndianOil Citibank Card -  We live for our family. have you secured them? -  India's No. 1 Property Site. Click here to know more.. -  Diseases earlier, Saving Costs, Extending Lives. Know More.. -  Get 5% cashback on telephone bills with Citi -  Enjoy the journey as much as the destination. click to know more.. -  Exim Bank Conclave on India - Africa Project Partnership. Know more.. -  Be part of it The World's Largest Aircraft. -  Creating Wealth made simple the SIP way. Know more.. -  Only Developer to give a guarantee on time space & rate. -  Office 365 for professionals and small businesses. -  Buy Your Property with Our Triple Guarantee in India. -  Improve Patient Care & Experience. Click here to know more -  Win a Business Class Ticket to Europe..Know more.. -   Introduce a New Automotive Luxury Car.. know more -  Health is Wealth..... Insurance + Savings... Know More...